184 related articles for article (PubMed ID: 9873712)
1. Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.
Sheppard GS; Florjancic AS; Giesler JR; Xu L; Guo Y; Davidsen SK; Marcotte PA; Elmore I; Albert DH; Magoc TJ; Bouska JJ; Goodfellow CL; Morgan DW; Summers JB
Bioorg Med Chem Lett; 1998 Nov; 8(22):3251-6. PubMed ID: 9873712
[TBL] [Abstract][Full Text] [Related]
2. Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.
Campbell DA; Xiao XY; Harris D; Ida S; Mortezaei R; Ngu K; Shi L; Tien D; Wang Y; Navre M; Patel DV; Sharr MA; DiJoseph JF; Killar LM; Leone CL; Levin JI; Skotnicki JS
Bioorg Med Chem Lett; 1998 May; 8(10):1157-62. PubMed ID: 9871727
[TBL] [Abstract][Full Text] [Related]
3. The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.
Levin JI; DiJoseph JF; Killar LM; Sharr MA; Skotnicki JS; Patel DV; Xiao XY; Shi L; Navre M; Campbell DA
Bioorg Med Chem Lett; 1998 May; 8(10):1163-8. PubMed ID: 9871728
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.
Groneberg RD; Burns CJ; Morrissette MM; Ullrich JW; Morris RL; Darnbrough S; Djuric SW; Condon SM; McGeehan GM; Labaudiniere R; Neuenschwander K; Scotese AC; Kline JA
J Med Chem; 1999 Feb; 42(4):541-4. PubMed ID: 10052961
[No Abstract] [Full Text] [Related]
5. Inhibition of gelatinase A by oleic acid.
Emonard H; Marcq V; Mirand C; Hornebeck W
Ann N Y Acad Sci; 1999 Jun; 878():647-9. PubMed ID: 10415797
[No Abstract] [Full Text] [Related]
6. Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).
Fray MJ; Dickinson RP
Bioorg Med Chem Lett; 2001 Feb; 11(4):571-4. PubMed ID: 11229774
[TBL] [Abstract][Full Text] [Related]
7. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
Hanessian S; Moitessier N; Gauchet C; Viau M
J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors: a structure-activity study.
Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
[TBL] [Abstract][Full Text] [Related]
10. The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
Levin JI
Curr Top Med Chem; 2004; 4(12):1289-310. PubMed ID: 15320727
[TBL] [Abstract][Full Text] [Related]
11. Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.
Curtin ML; Garland RB; Davidsen SK; Marcotte PA; Albert DH; Magoc TJ; Hutchins C
Bioorg Med Chem Lett; 1998 Jun; 8(12):1443-8. PubMed ID: 9873367
[TBL] [Abstract][Full Text] [Related]
12. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.
Santos MA; Marques S; Gil M; Tegoni M; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2003 Jun; 18(3):233-42. PubMed ID: 14506914
[TBL] [Abstract][Full Text] [Related]
14. Phosphonate inhibitors of adamalysin II and matrix metalloproteinases.
Gallina C; Gavuzzo E; Giordano C; Gorini B; Mazza F; Paglialunga-Paradisi M; Panini G; Pochetti G; Politi V
Ann N Y Acad Sci; 1999 Jun; 878():700-2. PubMed ID: 10415812
[No Abstract] [Full Text] [Related]
15. Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Benbow U; Maitra R; Hamilton JW; Brinckerhoff CE
Ann N Y Acad Sci; 1999 Jun; 878():662-4. PubMed ID: 10415801
[No Abstract] [Full Text] [Related]
16. Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.
Hanessian S; Bouzbouz S; Boudon A; Tucker GC; Peyroulan D
Bioorg Med Chem Lett; 1999 Jun; 9(12):1691-6. PubMed ID: 10397503
[TBL] [Abstract][Full Text] [Related]
17. A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: piperidine sulfonamide aryl hydroxamic acid analogs.
Kumaran S; Gupta SP
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):23-7. PubMed ID: 17373543
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitors.
Marcotte PA; Elmore IN; Guan Z; Magoc TJ; Albert DH; Morgand DW; Curtin ML; Garland RB; Guo Y; Heyman HR; Holms JH; Sheppard GS; Steinman DH; Wada CK; Davidsen SK
J Enzyme Inhib; 1999; 14(6):425-35. PubMed ID: 10536876
[TBL] [Abstract][Full Text] [Related]
19. Gelastatins, new inhibitors of matrix metalloproteinases from Westerdykella multispora F50733.
Lee HJ; Chung MC; Lee CH; Chun HK; Rhee JS; Kho YH
Ann N Y Acad Sci; 1999 Jun; 878():635-7. PubMed ID: 10415794
[No Abstract] [Full Text] [Related]
20. Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.
Fray MJ; Burslem MF; Dickinson RP
Bioorg Med Chem Lett; 2001 Feb; 11(4):567-70. PubMed ID: 11229773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
